131 related articles for article (PubMed ID: 3729450)
1. [Modulation of the anti-tumor effect of BRM under various nutritional or endocrine conditions].
Akimoto M; Nishihira T; Kasai M
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1270-6. PubMed ID: 3729450
[TBL] [Abstract][Full Text] [Related]
2. [Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments].
Akimoto M; Nishihira T; Mori S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):827-33. PubMed ID: 3260467
[TBL] [Abstract][Full Text] [Related]
3. [Effects of protein calorie intake on immuno- and chemotherapy].
Akimoto M; Abe R; Kasai M
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1387-93. PubMed ID: 6820915
[TBL] [Abstract][Full Text] [Related]
4. [Anti-cancer effects of BRMs associated with nutrition in cancer patients].
Nishihira T; Akimoto M; Mori S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1615-20. PubMed ID: 3382233
[TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
6. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells].
Yamagishi H; Naito K; Maeda Y; Kobayashi M; Kurioka H; Fujimori C; Tanaka T; Hashimoto I
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1670-8. PubMed ID: 6870309
[TBL] [Abstract][Full Text] [Related]
7. [Cumulative effects of lentinan and endocrine therapy on the growth of DMBA-induced mammary tumor in rats].
Kosaka A; Imaizumi A; Hatori Y; Mori F; Wani T; Yamashita A
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1399-407. PubMed ID: 6430243
[TBL] [Abstract][Full Text] [Related]
8. [Combined use of lentinan with X-ray therapy in an experimental mouse tumor system (Part 2). Combined effect on the MM102 syngeneic tumor].
Shiio T; Ohishi K; Tsuchiya Y; Niitsu I; Hayashibara H; Yoshihama T; Moriyuki H
Gan To Kagaku Ryoho; 1988 Mar; 15(3):475-9. PubMed ID: 3348633
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
Suga T; Shiio T; Maeda YY; Chihara G
Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173
[TBL] [Abstract][Full Text] [Related]
10. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
11. [Experimental studies on the enhanced effects of chemoendocrine therapy in breast cancer].
Abe R; Sawano A; Ueki H; Akimoto M; Kimura M
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):785-92. PubMed ID: 3566291
[TBL] [Abstract][Full Text] [Related]
12. [Antitumor effect of polysaccharide lentinan on C3H/He mice bearing MH134 ascites hepatoma].
Moriyama M; Miwa H; Moriya N; Orita K
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1102-7. PubMed ID: 6820909
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of 5-FU induced toxicity in C3 H/HE mice with interferon or with interferon inducers (poly 1: C, OK-432, Lentinan)].
Akimoto M; Ueki H; Nakajima Y; Matano S; Ewasaki H; Abe R; Kasai M
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1462-7. PubMed ID: 6204597
[TBL] [Abstract][Full Text] [Related]
14. Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors.
Gatanaga T; Takahashi K; Yamazaki M; Mizuno D; Abe S
Jpn J Cancer Res; 1985 Jul; 76(7):631-6. PubMed ID: 3928560
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study on the optimal treatment schedule for combination of BRM (immunostimulators, cultured killer cells or interleukin-2) and chemotherapy].
Kan N; Okino T; Satoh K; Mise K; Teramura Y; Yamasaki S; Harada T; Ohgaki K; Tobe T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1421-7. PubMed ID: 2389941
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
Gorelik E
Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083
[TBL] [Abstract][Full Text] [Related]
17. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
Cunningham C; Nemunaitis J
Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
19. [Reduction of 5-FU toxicity with improved nutritional status in tumor bearing mice].
Akimoto M; Ohuchi N; Matano S; Hirakawa H; Abe M; Nishihira T; Mori S
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3609-13. PubMed ID: 2479340
[TBL] [Abstract][Full Text] [Related]
20. [The effect of an arginine-imbalanced diet on the growth of implanted MM-48 and MH-134 tumors in C3H/He mice].
Akimoto M; Nakajima Y; Iwasaki H; Matano S; Hirakawa H; Abe R; Kasai M
Gan To Kagaku Ryoho; 1986 Feb; 13(2):330-6. PubMed ID: 2418792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
